
Randox announce Variants of Concern Panel
The Randox CE marked SARS-CoV-2 IgG RBD & NP array utilises patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). The SARS-CoV-2 IgG (RBD & NP) array is compatible with both capillary and venous blood collection.
























































Randox Laboratories Founded
Randox Laboratories Limited is founded by Dr Peter FitzGerald in April 1982
























































Reagents in the early years
Consisted of AST, ALT, ALP, CK-NAC, Gamma GT, LDH and HBDH, all of which are still produced today






































































































































































Visit from Northern Ireland Government Minister for Economic Development
- Northern Ireland Institute of Export Award
- SMART Award
- Northern Ireland Export Award
- Export Award for Smaller Businesses
- National Westminster Bank/DTI Travel Award for Shop Floor Worker

























































Visit to a now long-standing customer in Syria, the first of many international visits
- National Westminster Bank/DTI Travel Award for Shop Floor Worker
- Better Made in Britain Award
- SMART Award

























































1st Queen’s Award for Export Achievement
- European Business of the Year Award
- Gallagher Business Challenge Award






























































































































































































































Visit to Iraq secured another of our now many international partners. Today we still supply products to Iraq
- Opening of office in Germany
- Accredited to ISO 9002
- SMART Award
















































































































Mrs FitzGerald is awarded the Order of the British Empire (OBE), for services to business in Northern Ireland
- Opening of offices in Slovakia, Czech Republic, Spain and the United States of America







































































































































































We extended our headquarters to facilitate increasing manufacturing demands
- Accredited to ISO 9001
- 4th Queen’s Award for Enterprise

























































Launch of the first biochip analyser, Evidence
- Completion of the development of Biochip Array Technology
- Opening of office in China
- RIQAS accredited with UKAS approval, the International accreditation for the provision of proficiency testing programmes

























































Launch of our first clinical chemistry analyser, RX daytona
- Royal Academy of Engineering MacRobert Award for the Evidence analyser
- The Evidence analyser was displayed for a year in the London Science museum after winning the prestigious MacRobert Award
- Accredited to ISO 13485
- Launch of Acusera 24-7 Internal Quality Control (IQC) peer group reporting package
- Royal Academy of Engineering MacRobert Award for the Evidence analyser

























































Launch of the second biochip analyser, Evidence Investigator
- Ernst & Young Entrepreneur of The Year 2004







































































































































































Confederation of British Industry Growing Business Award
- Chartered Institute of Marketing Award
- Chamber of Commerce Regional Award
- Chamber of Commerce Regional Award
- Frost & Sullivan European Technology Innovation of the Year Award
- Northern Ireland International Trade Award
- 5th Queen’s Award for Enterprise International Trade award

























































The opening of our site in Dungloe, County Donegal for analyser manufacture and Research & Development
- Belfast Telegraph Northern Ireland Business Awards

























































Launch of the third biochip analyser, Evidence MultiStat which was designed to bring testing to the bedside or site of patient care
- UTV Business Personality of the Year Award - Dr Peter FitzGerald outright winner
- South Antrim Business Awards
- Manufacturing Excellence Awards
- Invest NI Innovation & Export Awards
- We were honoured with a second Royal visit by HRH Prince Andrew
- Total re-branding programme to Randox corporate identity incorporating a red dot symbolising a drop of blood

























































Launch of the fourth biochip analyser, Evidence Evolution
- International Trade Company of the Year Award
- Exporting Achievement Award
- Opening of a new facility in West Virginia, USA to expand our manufacturing and distribution capabilities
- Randox Health Checks Limited was launched in Northern Ireland bringing health screening to the public
- Marketing Excellence Award: Manufacturing Sector

























































Dr Peter FitzGerald is appointed as Commander of the Order of the British Empire (CBE), for services to business in Northern Ireland
- Launch of the fourth clinical chemistry analyser, RX suzuka
- Opening of a 30,000 square feet facility in Bangalore, India
- Launch of two new companies

























































Randox Health Checks opens in the centre of London
- Randoc Health open a state of the art facility to provide a top class testing service which offers a comprehensive picture of health
- Launch of the fifth clinical chemistry analyser, RX daytona plus

























































Randox Biosciences Created
- Randox invests £15 million in R&D ‘Roadmap’ to target the international personalised medicine market






















































